🇺🇸 FDA
Pipeline program

XTL 6865

XTL2005-16

Phase 1 small_molecule active

Quick answer

XTL 6865 for Hepatitis C is a Phase 1 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
XTL BIOPHARMACEUTICALS LTD
Indication
Hepatitis C
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials